Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: A cohort study

The Lancet Global Health

Volumn 2, Issue 7, 2014, Pages e422-e430

  Vincent, Quentin B ^a,b   Ardant, Marie Françoise ^c,d   Adeye, Ambroise ^c,d   Goundote, Aimé ^c,d   Saint André, Jean Paul ^e   Cottin, Jane ^e   Kempf, Marie ^e   Agossadou, Didier ^f   Johnson, Christian ^d   Abel, Laurent ^a,b,g   Marsollier, Laurent ^e   Chauty, Annick ^c,d   Alcaïs, Alexandre ^a,b,g,h  

^a IMAGINE INSTITUTE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Centre de Dépistage et de Traitement de l Ulcère de Buruli CDTUB   (Benin)

^d Fondation Raoul Follereau   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f MINISTÈRE DE LA SANTÉ   (Benin)

^g ROCKEFELLER UNIVERSITY   (United States)

^h Unité de Recherche Clinique Paris Centre Descartes Necker Cochin Assistance Publique HÔpitaux de Paris   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BURULI ULCER; CHILD; CLINICAL FEATURE; EDEMA; FEMALE; GENDER; HUMAN; LABORATORY TEST; LEG DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NODULE; OSTEOMYELITIS; PLAQUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAINING; AGE DISTRIBUTION; BENIN; BLOOD; COHORT ANALYSIS; COMORBIDITY; FOLLOW UP; SEX RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BENIN; BURULI ULCER; CAUSALITY; CHILD; COHORT STUDIES; COMORBIDITY; EDEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OSTEOMYELITIS; PROSPECTIVE STUDIES; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84925450861     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70223-2     Document Type: Article

References (40)

1. Sizaire V, Nackers F, Comte E, Portaels F Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis 2006, 6:288-296.
2. Buruli ulcer disease factsheet WHO, (accessed April 3, 2012). http://www.who.int/mediacentre/factsheets/fs199/en/index.html.
3. Debacker M, Aguiar J, Steunou C, et al. Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001. Emerg Infect Dis 2004, 10:1391-1398.
4. Buruli ulcer: progress report, 2004-2008. Wkly Epidemiol Rec 2008, 83:145-154. WHO.
5. Merritt RW, Walker ED, Small PLC, et al. Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis 2010, 4:e911.
6. Jacobsen KH, Padgett JJ Risk factors for Mycobacterium ulcerans infection. Int J Infect Dis 2010, 14:e677-e681.
7. Pouillot R, Matias G, Wondje CM, et al. Risk factors for buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis 2007, 1:e101.
8. Landier J, Boisier P, Fotso Piam F, et al. Adequate wound care and use of bed nets as protective factors against Buruli Ulcer: results from a case control study in Cameroon. PLoS Negl Trop Dis 2011, 5:e1392.
9. Marston BJ, Diallo MO, Horsburgh CR, et al. Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. Am J Trop Med Hyg 1995, 52:219-224.
10. Marsollier L, Robert R, Aubry J, et al. Aquatic insects as a vector for Mycobacterium ulcerans. Appl Environ Microbiol 2002, 68:4623-4628.
11. Johnson PD, Azuolas J, Lavender CJ, et al. Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis 2007, 13:1653-1660.
12. Meyers WM, Shelly WM, Connor DH, Meyers EK Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg 1974, 23:919-923.
13. Epidemiology of Mycobacterium ulcerans infection (Buruli ulcer) at Kinyara, Uganda. Trans R Soc Trop Med Hyg 1971, 65:763-775. No authors listed.
14. Amofah G, Bonsu F, Tetteh C, et al. Buruli ulcer in Ghana: results of a national case search. Emerging Infect Dis 2002, 8:167-170.
15. Debacker M, Aguiar J, Steunou C, et al. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 2004, 9:1297-1304.
16. Debacker M, Portaels F, Aguiar J, et al. Risk factors for Buruli ulcer, Benin. Emerg Infect Dis 2006, 12:1325-1331.
17. Sopoh GE, Johnson RC, Chauty A, et al. Buruli ulcer surveillance, Benin, 2003-2005. Emerg Infect Dis 2007, 13:1374-1376.
18. Hospers IC, Wiersma IC, Dijkstra PU, et al. Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission. Trans R Soc Trop Med Hyg 2005, 99:196-201.
19. Wansbrough-Jones M, Phillips R Buruli ulcer: emerging from obscurity. Lancet 2006, 367:1849-1858.
20. Royston P, Ambler G, Sauerbrei W The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999, 28:964-974.
21. Wickham H ggplot2: elegant graphics for data analysis 2009, Springer, New York, (accessed May 21, 2014). http://had.co.nz/ggplot2/book.
22. Team RDC R: a language and environment for statistical computing 2014, Vienna, Austria, (accessed May 21, 2014). http://www.R-project.org/.
23. Sauerbrei W, Meier-Hirmer C, Benner A, Royston P Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs. Computational Statistics & Data Analysis 2006, 50:3464-3485.
24. World population prospects: the 2012 revision, highlights and advance tables, 2013 United Nations, Department of Economic and Social AffairsDepartment of Economic and Social Affairs, Population DivisionPopulation Division, (accessed May 21, 2014). http://esa.un.org/unpd/wpp/index.htm.
25. Raghunathan PL, Whitney EAS, Asamoa K, et al. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): results from a case-control study in Ghana. Clin Infect Dis 2005, 40:1445-1453.
26. Barker DJ Epidemiology of Mycobacterium ulcerans infection. Trans R Soc Trop Med Hyg 1973, 67:43-50.
27. Portaels F, Silva MT, Meyers WM Buruli ulcer. Clin Dermatol 2009, 27:291-305.
28. Boleira M, Lupi O, Lehman L, Asiedu KB, Kiszewski AE Buruli ulcer. An Bras Dermatol 2010, 85:281-298.
29. Silva MT, Portaels F, Pedrosa J Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. Lancet Infect Dis 2009, 9:699-710.
30. Iredell J, Whitby M, Blacklock Z Mycobacterium marinum infection: epidemiology and presentation in Queensland 1971-1990. Med J Aust 1992, 157:596-598.
31. Casal M, Casal MM Multicenter study of incidence of Mycobacterium marinum in humans in Spain. Int J Tuberc Lung Dis 2001, 5:197-199.
32. Ang P, Rattana-Apiromyakij N, Goh CL Retrospective study of Mycobacterium marinum skin infections. Int J Dermatol 2000, 39:343-347.
33. Neyrolles O, Quintana-Murci L Sexual inequality in tuberculosis. PLoS Med 2009, 6:e1000199.
34. Britton WJ, Lockwood DNJ Leprosy. Lancet 2004, 363:1209-1219.
35. Yamamoto Y, Saito H, Setogawa T, Tomioka H Sex differences in host resistance to Mycobacterium marinum infection in mice. Infect Immun 1991, 59:4089-4096.
36. Portaels F, Aguiar J, Debacker M, et al. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun 2004, 72:62-65.
37. Peltola H, Pääkkönen M Acute osteomyelitis in children. N Engl J Med 2014, 370:352-360.
38. Röltgen K, Qi W, Ruf M-T, Mensah-Quainoo E, et al. Single nucleotide polymorphism typing of Mycobacterium ulcerans reveals focal transmission of buruli ulcer in a highly endemic region of Ghana. PLoS Negl Trop Dis 2010, 4:e751.
39. Buruli ulcer epidemiological situation WHO, (accessed May 21, 2014). http://apps.who.int/neglected_diseases/ntddata/buruli/buruli.html.
40. O'Brien DP, Comte E, Serafini M, et al. The urgent need for clinical, diagnostic, and operational research for management of Buruli ulcer in Africa. Lancet Infect Dis 2014, 14:435-440.